<10-Q 3/31/07
Alliacense has held licensing discussions with Kodak and many other companies regarding a portfolio of patents directed to microprocessors. Allegedly, these patents would implicate products in all of Kodak’s businesses, including the Health Group. Kodak does not make its own microprocessors, so is seeking indemnification from its suppliers. Several of these patents are being re-examined by the USPTO.>
Does anyone have any thoughts on the highlighted sentance? Who would give them indemnification? I was under the impression that we are offering two different licenses. One for chipmakers and another for users of the chips (system?). If that is correct, then the statement makes no sense. What am I missing? Opty